Hydrocortisone suppositories are expensive primarily because the market for rectal medications is small, manufacturing is specialized, and very few companies bother competing to make them. A box of 12 suppositories at the 30mg strength can run over $180 at retail without a coupon, and even the lower 25mg dose costs around $31 for the same quantity. For a decades-old steroid that costs pennies to produce in cream form, those prices feel absurd. The reasons come down to market dynamics rather than the drug itself.
A Niche Product With Few Manufacturers
Hydrocortisone is one of the oldest and cheapest corticosteroids available. In cream or ointment form, you can buy it over the counter for a few dollars. But the suppository version exists in a much smaller market. Relatively few people need rectal hydrocortisone compared to, say, the millions who use topical hydrocortisone for skin irritation. That small patient population means fewer sales, which means fewer manufacturers see it as worth producing.
Manufacturing suppositories also requires different equipment and processes than making pills or creams. The drug has to be formulated into a solid base that melts at body temperature and releases the medication at the right rate. Facilities that produce rectal dosage forms are less common, and the setup costs don’t scale down just because the market is small. When only one or two companies make a product, there’s little competitive pressure to lower the price.
Expired Patents, but No Price Drop
The brand-name versions of these suppositories, Anusol-HC (25mg) and Proctocort (30mg), lost their patent protection years ago. Salix Pharmaceuticals, which acquired exclusive selling rights to both products in 2004, acknowledged in SEC filings that these were “mature products” with no remaining patents or data exclusivity. In theory, that should have opened the door to generic competition and lower prices.
In practice, generics haven’t driven prices down the way they do for blockbuster drugs. The economics simply don’t attract many generic manufacturers. Developing a generic suppository still requires filing with the FDA, demonstrating bioequivalence, and maintaining a specialized production line. For a product with a small customer base, the potential revenue often doesn’t justify that investment. The result is a market with minimal competition, where even “generic” versions carry surprisingly high price tags. The 30mg strength is a clear example: retail prices averaging over $180 suggest very few companies are making it.
The 25mg vs. 30mg Price Gap
One of the more puzzling aspects is the price difference between the two available strengths. A box of twelve 25mg suppositories averages around $31 at retail, while the same quantity of 30mg suppositories averages $183. The active ingredient costs are nearly identical for such a small dose difference, so the price gap reflects market structure, not manufacturing costs. The 30mg strength likely has even fewer manufacturers than the 25mg, giving whatever company produces it significant pricing power. If your prescription specifies 30mg, it’s worth asking your doctor whether the 25mg strength would work for your situation.
How Insurance Handles Coverage
Insurance coverage varies widely. The VA health system lists hydrocortisone rectal suppositories as a standard formulary item at a Tier 2 copay, which typically means a moderate out-of-pocket cost for veterans. Private insurance plans are less predictable. Some commercial formularies cover hydrocortisone suppositories without restrictions, while others may require prior authorization or place them on a higher copay tier. If your plan doesn’t cover them or you’re paying cash, discount programs like GoodRx can bring the 30mg price down to roughly $56 for a box of 12, a significant reduction from the $183 retail average.
Alternatives That May Cost Less
If suppository costs are a barrier, other rectal hydrocortisone formulations exist, though they come with their own pricing quirks. Hydrocortisone rectal foam and retention enemas deliver the same drug to the same area. Enemas tend to be less expensive per dose than foam, but both carry meaningful daily costs. Rectal foam, for instance, runs in the range of $3 to $7 per dose depending on how frequently it’s used. These alternatives aren’t always interchangeable with suppositories, since the delivery method affects where the medication concentrates, but they’re worth discussing with a prescriber if price is a concern.
Over-the-counter hydrocortisone rectal creams are another option for milder symptoms. They deliver a lower concentration of hydrocortisone and work best for external irritation rather than internal inflammation. For conditions like ulcerative proctitis or internal hemorrhoids that specifically call for a suppository, the OTC creams aren’t a direct substitute.
Why This Problem Persists
The hydrocortisone suppository market is a textbook case of what happens when a drug is too old to be patented but too niche to attract generic competition. The FDA has tried to address this broader pattern through programs that encourage generic manufacturers to enter underserved markets, but progress is slow. Small-market drugs with specialized dosage forms remain some of the most persistently overpriced products in American pharmacies. The drug itself is cheap. The formulation is straightforward. But without enough companies willing to make and sell the product, prices stay high because they can.